Global Inhaler Market 2022-2028

Global Inhaler Market 2022-2028

The global inhaler market is growing at a CAGR of 5.9% during the forecast period. Increasing the adoption of therapies is one of the prime factors affecting and driving the market. Additionally, breathing problems due to increasing air pollution caused through various vehicles along with factories through the emission of harmful particles, are also estimated to be the prime factors that are contributing significantly towards the growth of the market. However, lack of skilled physicians, high cost of an inhaler along with lack of device use are major factors constraints that are hindering the growth of the global inhaler market.

Moreover, emerging preferences for miniature and compact devices are the key factors that are creating opportunities in the market. New launches in the market are likely to drive the growth of the global inhaler market. For instance, in November 2021, Teva Pharmaceutical Industries Ltd., had notified the launch of Proair Digihaler that is an inhalation powder. This device will support bringing a new digital health tool to patients suffering from asthma and Chronic Obstructive Pulmonary Disease (COPD). Additionally, it is attributed to Bluetooth wireless technology sensors which are inbuilt in it. The technology sensors will enable the device to connect with a mobile application in order to provide proper information.

Impact of COVID-19 Pandemic on the Global Inhaler Market

The global inhaler market is hardly hit by the COVID-19 pandemic since December 2021. The COVID-19 pandemic in the major economies had disrupted various activities. Additionally, the utilization of inhaled corticosteroids (ICS) was lower in patients who required hospitalization due to COVID-19, as compared to non-hospitalized patients. However, as the lockdown restrictions are lifted the market is showing a steady recovery.

Segmental Outlook

The market is segmented based on devices, applications, and end-user. By devices, the market is segmented into metered dose inhaler, dry powder inhaler, nebulizer, and nasal. Further, based on the applications segment, the market is segmented into asthma and chronic obstructive pulmonary disease. By end-user, the market is segmented into home care and hospitals & clinics.

lungs as when the medicine is taken by the person it sets inside in the form of powder, and the person or the patient is required to breathe deep and fast. This would lead to getting the proper amount of medicine to be utilized in the lungs. The dry powder inhaler causes lesser irritant effects along with its easier-to-use attribute when compared with a metered-dose inhaler. Additionally, this inhaler is portable and compact as well which is also supporting its usage.

Regional Outlooks

Global Inhaler Market is analyzed based on the geographical regions that are contributing significantly towards the growth of the market. Based on the geography, the market is bifurcated into North America, Europe, Asia Pacific, and the Rest of the World. North America is estimated to be one of the growing regions in the global inhaler market. Some factors that are boosting the market growth in North America are awareness programs organized by governments and organizations, improving treatment options for Chronic Obstructive Pulmonary Disease (COPD). Moreover in Europe, the rising pervasiveness of respiratory diseases and non-respiratory diseases along with the presence of key market players are some of the factors that are driving the growth of the inhaler market in Europe.

Asia-Pacific will have considerable growth in the Global Inhaler Market

Asia-Pacific is considered to be an opportunistic and most emerging market due to the significant improvement in the healthcare system. The rising incidence of chronic respiratory diseases such as asthma and COPD is also one of the major factors for the growth of the market in the Asia-Pacific region. Additionally, the increasing R&D and investments by big pharmaceutical companies in life science research coupled with harnessing innovation are also some of the other factors that are impacting the growth of the market in the region.

Market Players Outlook

Key players of the global inhaler market are AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc., Koninklijke Philips N.V., and OMRON Healthcare Europe B.V. To survive in the market, these players adopt different marketing strategies such as product launches and mergers and acquisitions. For instance, in December 2021, Omron Healthcare Europe B.V. had introduced a home use wheeze detection device that will support in the detection of wheezing which is a common asthmatic symptom that is generally observed in children aged less than five. The device would also identify a sound with its listening technology in a child’s wheezing which cannot be listened too easily.

In September 2021, Boehringer Ingelheim International GmbH announced the launch of the first FDA-approved inhalant therapy that is Aservo Equihaler for horses suffering from equine asthma.

In May 2021, Glenmark Pharmaceutical Inc. had highlighted the launch of a single inhaler triple therapy AIRZ-FF for people suffering from Chronic Obstructive Pulmonary Disease (COPD). The therapy will support making breathing easier along with decreasing dependency on multiple inhalers.

In November 2021, one of the drug makers named lupin that had launched a device that will be useful for people suffering from chronic respiratory diseases that includes Chronic Obstructive Pulmonary Disease (COPD) and Asthma. This device will be effective for the purpose of tracking the usage pattern of metered-dose inhalers.

The Report Covers

Market value data analysis of 2021 and forecast to 2028.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global inhaler market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying ‘who-stands-where’ in the market.